This course closed on Friday, October 21, 2022

Please Login to participate

Great Debates and Updates in Temperature Management

FACULTY

Topic #1: Practice Changing Updates Panel: ERAS® Society Guidelines Recommendation for Prevention of Perioperative Hypothermia

Kari M. Cole, Ed.D, CRNA
Chief Nurse Anesthetist, LAC + USC Medical Center
Assistant Clinical Professor 
Keck School of Medicine of USC
Los Angeles, California

Dr Hans D. de Boer, MD, PhD. 
Anesthesiologist and Pain Specialist
Department of Anesthesiology, Pain Medicine and Procedural Sedation and Analgesia
Martini General
Hospital Groningen
Groningen, Netherlands

Cathleen Ferguson, RN, BScN, RNFA, CPN(C)
ERAS Coordinator
St Martha's Hospital
Antigonish Nova Scotia
Antigonish, Canada

 

Topic #2: Impact of Inadvertent Perioperative Hypothermia: Causes and Consequences

Kari M. Cole, Ed.D, CRNA
Chief Nurse Anesthetist, LAC + USC Medical Center
Assistant Clinical Professor 
Keck School of Medicine of USC
Los Angeles, California

Daniel I. Sessler MD
Michael Cudahy Professor & Chair
Department of Outcomes Research
Cleveland, Ohio

 

Topic #3: Great Debates and Updates in Temperature Monitoring

Kari M. Cole, Ed.D, CRNA
Chief Nurse Anesthetist, LAC + USC Medical Center
Assistant Clinical Professor 
Keck School of Medicine of USC
Los Angeles, California

Daniel I. Sessler MD
Michael Cudahy Professor & Chair
Department of Outcomes Research
Cleveland, Ohio

 

PROVIDER STATEMENT

Provided by HMP Education, an HMP Global Company.

For questions regarding this educational activity, or to cancel your account, please call 609-371-1137 or email accreditation@hmpglobal.com.

INTENDED LEARNERS

This activity is designed for anesthesiologists and Certified Nurse Anesthetists (CRNAs).

LEARNING OBJECTIVES

Topic #1: Practice Changing Updates Panel: ERAS® Society Guidelines Recommendation for Prevention of Perioperative Hypothermia

After participating in this activity, learners should be able to: 

  • Explain the importance of temperature management during all phases of the perioperative journey
  • Describe warming protocols implemented to support an ERAS® bundle
  • Discuss key metrics used to evaluate warming protocols
  • Outline strategies to collaborate with industry partners to have a successful implementation
  • Discuss the importance of a multidisciplinary team approach when implementing ERAS bundle/Patient warming protocol
  • Discuss the role of Patient engagement in successful implementation of ERAS guidelines

 

Topic #2: Impact of Inadvertent Perioperative Hypothermia: Causes and Consequences

After participating in this activity, learners should be able to: 

  • Know the true core temperature monitoring sites, other generally reliably monitoring sites, and which sites are often unreliable
  • Understand the normal thermoregulatory system, including afferent input, central control, and afferent defenses
  • Understand the importance of perioperative warming, including benefits of pre-operative warming ("heat banking”)  via warming gowns, maintenance of warming efforts throughout induction and surgical prep, and requires teamwork
  • Understand the importance of ongoing education and engagement regarding importance of perioperative temperature management

 

Topic #3: Great Debates and Updates in Temperature Monitoring

After participating in this activity, learners should be able to: 

  • Be able to describe the effects of general anesthesia on warm and cold response thresholds
  • Understand the etiology of each phase of the hypothermia curve
  • Understand the importance of perioperative temperature monitoring, discuss key metrics to evaluate warming protocol, and potential benefit of consistent thermometry method throughout perioperative process to reduce thermometry variation
  • Understand the importance of maintaining patient safety and standards of practice: ASA/AANA/APSF/AORN

ACTIVITY OVERVIEW

To be eligible for credit, participants must complete the educational activity, complete the pre-test and post-test, and complete the evaluation form. Upon completing the activity, there will be instructions on how to complete the evaluation and print a certificate or other documentation of credit.

Release Date: September 21, 2022 
Expiration Date: October 21, 2022 
Estimated Time to Complete: 2.5 hours

There is no fee associated with this activity.

HARDWARE/SOFTWARE REQUIREMENTS

The evaluation is accessible after the activity via a PC or Mac computer with current versions of the following browsers: Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications. 

CONTINUING EDUCATION

In support of improving patient care, HMP Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIANS

HMP Education designates this internet live activity for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSES

This continuing nursing education internet live activity awards 2.5 contact hours.

Provider approved by the California Board of Registered Nursing, Provider #13255 for 2.5 contact hours. 

NURSE PRACTITIONERS

American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 CreditTM from organizations accredited by the ACCME.

PHYSICIAN ASSISTANTS

HMP Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This internet live activity is designated for 2.5 AAPA Category 1 credits. PAs should only claim credit commensurate with the extent of their participation.

USE OF PROPRIETARY NAMES

This continuing medical education activity may include device or medicine brand names for participant clarity purposes only, due to the presence of different branded versions of the same product. No product promotion or recommendation should be inferred.

UNAPPROVED AND/OR INVESTIGATIONAL USES OF DRUGS AND DEVICES

This activity may contain information about experimental and other uses of drugs or devices that are not currently approved by the European Medicines Agency (EMA) of the European Union or the Food and Drug Administration (FDA) of the United States. Participants are strongly encouraged to consult approved product labeling for any drug or device mentioned in this activity before use. The opinions expressed during this activity are the opinions of the respective authors, presenters or moderators and do not necessarily reflect the opinions of HMP Education.

DISCLAIMERS

The material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.

Neither HMP Education nor any of its subsidiaries or affiliates is affiliated with, or formally endorsed by a medical society.

The opinions expressed in this educational activity are those of the faculty and are not attributable to HMP Education or HMP. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS

HMP Education is an independent provider of continuing medical education. HMP Education has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.

In accordance with our disclosure policies, HMP Education is committed to ensuring balance, independence, objectivity, and scientific rigor for all accredited continuing education. These policies include assigning relevance to, and mitigating, all perceived or real conflicts of interest between any individual with control over the content and any ineligible company (commercial interest) as defined by the ACCME.

Any individual with control over accredited content, including planner, faculty, and reviewer, is required to globally disclose:

  1. Individual relationship(s) or lack thereof, and its nature, with any/all ineligible company, and;
  2. Any investigational, off-label, or non-FDA approved content or discussion

HMP Education has reviewed these disclosures, assigned relevance based on the relationship and scope of content, and identified those with the potential to compromise the goals and educational integrity of the education. Relevant relationships, or lack thereof, are shared with the learner.

Education has been independently peer-reviewed to validate content, mitigate identified conflicts of interest, and ensure:

  1. All recommendations involving clinical medicine is based on evidence that is accepted within the medical profession as adequate justification for their indications and contraindications in the care of patients.
  2. All scientific research referred to, reported, or used in accredited continuing education in support or justification of a patient care recommendation conforms to the generally accepted standards of experimental design, data collection, and analysis.
  3. Content is appropriate, fair and balanced, unbiased, referenced, and non-promotional.

FACULTY

The faculty has reported the following:

Ms. Ferguson: Educational Consultant – 3M
Dr. Sessler: Consulting – 3M, BlueSpark, Calorent, TransQtronic

Dr. Cole and Dr. de Boer have disclosed no relevant financial relationships with any ineligible companies (commercial interests).

CLINICAL REVIEWER

Daniel Federman, MD, FACP
Professor of Medicine
Yale University School of Medicine
Associate Chief of Medicine
VA Connecticut Healthcare System
West Haven, Connecticut

Dr. Federman has disclosed no relevant financial relationship with any ineligible company (commercial interest).

PLANNING COMMITTEE

Susie Seaman, NP, MSN, CWCN, CWS (nurse planner)
Wound Clinic, Family Health Centers of San Diego
San Diego, California

Ms. Seaman has disclosed no relevant financial relationship with any ineligible company (commercial interest).

HMP Education planners and staff include Samantha Bella, Samantha Conforti, Tiffney Oliver, Randy Robbin, Lacey Schmeidler, and Andrea Zimmerman.

No HMP Education planner or staff has disclosed a relevant financial relationship with any ineligible company (commercial interest).

ADA STATEMENT

HMP Education complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 609-371-1137.

PRIVACY POLICY

HMP Education protects the privacy of personal and other information regarding participants, educational partners, and joint providers. HMP Education and our joint providers will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. HMP Education maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2022 by HMP Education. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from HMP Education.

GRIEVANCE POLICY

Any participant wanting to file a grievance with respect to any aspect of a continuing education activity accredited by HMP Education may contact Samantha Conforti, Senior Manager, Accreditation and Compliance, by phone at 609-371-1137, by email at sconforti@hmpglobal.com or in writing at 104 Windsor Center Drive, East Windsor, NJ 08520. Ms. Conforti will review the grievance and respond within 30 days of receiving the complaint.

COMMERCIAL SUPPORT

Supported by an independent educational grant from 3M Health Care, Medical Solutions Division.